Abstract
The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Current Pharmaceutical Biotechnology
Title: Molecular Recognition Mechanisms for Detecting Cell Death In Vivo
Volume: 11 Issue: 6
Author(s): Ming Zhao
Affiliation:
Keywords: Apoptosis, Necrosis, Imaging, Probe
Abstract: The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Export Options
About this article
Cite this article as:
Zhao Ming, Molecular Recognition Mechanisms for Detecting Cell Death In Vivo, Current Pharmaceutical Biotechnology 2010; 11 (6) . https://dx.doi.org/10.2174/138920110792246591
DOI https://dx.doi.org/10.2174/138920110792246591 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Withdrawal Notice: Recent Developments in Anti-Cancer Activity of Compounds Containing the Thioether Group
Anti-Cancer Agents in Medicinal Chemistry Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Editorial (Thematic Issue: Treatment of Cancer in the Elderly)
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21
Current Pharmaceutical Design Carcinogenesis and Therapeutic Strategies in Thyroid Cancer
Current Drug Targets Transbronchial Needle Aspiration (TBNA): Past Present and Future
Current Respiratory Medicine Reviews Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis
Current Medicinal Chemistry Green Biofactories: Recombinant Protein Production in Plants
Recent Patents on Biotechnology Role of Platelets in Angiogenesis in Health and Disease
Current Angiogenesis (Discontinued) P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
Current Signal Transduction Therapy Bridging the Gap Between Chemistry and Biotechnology - Large Molecules with Potential, How Could Biotechnology Complement Chemistry?
Current Organic Chemistry Anticarcinogenic Effects of Capsaicin-Loaded Nanoparticles on In vitro Hepatocellular Carcinoma
Current Chemical Biology Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Bench to Bedside Targeting of FLT3 in Acute Leukemia
Current Drug Targets Medicinal Chemistry of Sirtuin Inhibitors
Current Medicinal Chemistry Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle
Current Medicinal Chemistry Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine DNA Methylation as a Target of Epigenetic Therapeutics in Cancer
Anti-Cancer Agents in Medicinal Chemistry Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry